HWAM
BMY icon

Hennion & Walsh Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Hennion & Walsh Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
18,045
-450
-2% -$25.8K 0.03% 554
2026
Q1 		$1.12M Buy
18,495
+5,688
+44% +$332K 0.04% 480
2025
Q4 		$691K Sell
12,807
-109
-0.8% -$5.24K 0.02% 621
2025
Q3 		$583K Sell
12,916
-5,342
-29% -$249K 0.02% 669
2025
Q2 		$845K Buy
18,258
+888
+5% +$43.6K 0.03% 530
2025
Q1 		$1.06M Sell
17,370
-6,328
-27% -$369K 0.05% 460
2024
Q4 		$1.34M Sell
23,698
-12,114
-34% -$677K 0.06% 396
2024
Q3 		$1.85M Sell
35,812
-18,552
-34% -$870K 0.09% 298
2024
Q2 		$2.26M Sell
54,364
-6,088
-10% -$272K 0.12% 231
2024
Q1 		$3.28M Sell
60,452
-3,101
-5% -$158K 0.18% 150
2023
Q4 		$3.26M Sell
63,553
-276
-0.4% -$14.5K 0.19% 145
2023
Q3 		$3.7M Sell
63,829
-4,757
-7% -$291K 0.24% 104
2023
Q2 		$4.39M Buy
68,586
+2,660
+4% +$178K 0.26% 91
2023
Q1 		$4.57M Sell
65,926
-5,560
-8% -$392K 0.28% 83
2022
Q4 		$5.14M Buy
71,486
+7,781
+12% +$587K 0.32% 74
2022
Q3 		$4.53M Sell
63,705
-6,623
-9% -$480K 0.3% 79
2022
Q2 		$5.42M Buy
70,328
+5,450
+8% +$415K 0.34% 72
2022
Q1 		$4.74M Buy
64,878
+2,626
+4% +$176K 0.25% 102
2021
Q4 		$3.88M Buy
62,252
+3,296
+6% +$193K 0.19% 142
2021
Q3 		$3.49M Sell
58,956
-3,055
-5% -$201K 0.18% 160
2021
Q2 		$4.14M Buy
62,011
+7,759
+14% +$506K 0.22% 116
2021
Q1 		$3.42M Buy
+54,252
New +$3.38M 0.21% 130

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Hennion & Walsh Asset Management's BMY Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, selling an estimated $25.8K and leaving 18,045 shares worth $1.04M. The position accounts for 0.03% of the portfolio, ranked #554.

Hennion & Walsh Asset Management first reported a position in BMY in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.42M in Q2 2022. 909 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hennion & Walsh Asset Management held 18,045 shares of Bristol-Myers Squibb worth $1.04M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 450 Bristol-Myers Squibb shares in Q2 2026, an estimated $25.8K.
  • Bristol-Myers Squibb made up 0.03% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #554 holding.
  • Hennion & Walsh Asset Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's Bristol-Myers Squibb position peaked at $5.42M in Q2 2022.
  • 909 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.